Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
GPT Healthcare IPO
GPT Healthcare Limited
₹14,160 /80 sharesMinimum Investment
GPT Healthcare IPO Details
| Bidding Dates | Min. Investment | Lot Size | Price Range |
|---|---|---|---|
| 22 Feb ‘24 - 26 Feb ‘24 | ₹14,160 | 80 | ₹177 - ₹186 |
| Issue Size | IPO Doc |
|---|---|
| 525.14Cr | RHP PDF |
Subscription rate
| Qualified Institutional Buyers | 17.30x |
| Non-Institutional Investor | 11.02x |
| Retail Individual Investor | 2.44x |
| Total | 8.52x |
About GPT Healthcare
Founded in
1989
Managing director
Dr. Om Tantia
Parent organisation
GPT Healthcare Limited
Strengths & Financials of GPT Healthcare
Strengths
Risks
As per a CRISIL report for Fiscal year 2023, GPT Healthcare is one of the key regional corporate healthcare companies in Eastern India in terms of number of beds and hospitals. The company has been operational in the region for the past 20 years.
The company has a diversified service portfolio as a multispecialty healthcare platform. This has allowed it to have diversified revenue streams. In addition to providing core medical, surgical, and emergency services, it provides complex and advanced healthcare in specialities, such as nephrology (including renal transplants), diabetology etc.
The company has expanded over the years by increasing the bed capacity of its hospitals from eight beds in July 2000 to 561 beds as of September 30, 2023. Its team of medical professionals have also increased over the years. From a staff of 945 in 2021, the company has a team of 1312 medical professionals as of Sep 30, 2023.
It reported total operational revenues of Rs. 361.04 cr, Rs. 337.42 cr, and Rs. 242.75 cr, for Fiscal Years 2023, 2022, and 2021 respectively.
The company generates about 70% of its operational revenue from hospitals located in West Bengal, serving a substantial portion of its patient base. With all hospitals situated in the eastern region of India, any adverse effects on the revenue or alterations in the economic or political landscape of West Bengal could have a significant impact on the company's business, financial condition, operational results, and cash flows.
A member of the Promoter Group, Ishwari Prasad Tantia, has been listed as a Wilful Defaulter by some financial institutions. Future adverse actions or penalties against any Promoter Group member or associated entities by banks, RBI, SEBI, or regulatory authorities may adversely affect the company's reputation and business operations.
The company, along with its Promoters and Directors, is involved in certain legal proceedings, and any adverse developments may impact its operations. Potential litigation expenses and liabilities could adversely affect the company's reputation, business, financial condition, and cash flows.
The company has certain commitments and contingent liabilities that may adversely affect its financial condition. As of September 2023, its contingent liabilities amounted to Rs. 1.8 cr.
The company relies on third-party suppliers and manufacturers for supplies and equipment. Failure of such third parties to meet their obligations could adversely affect the business, results of operations and cash flows.
GPT Healthcare Financials
*All values are in Rs. Cr
No Graph Data To Display
Application Details of GPT Healthcare IPO
| Apply as | Price band | Apply Range |
|---|---|---|
| Regular | ₹177 - 186 | Upto ₹2 Lakh |
| High Networth Individual | ₹177 - 186 | ₹2 - 5 Lakh |
For GPT Healthcare IPO, eligible investors can apply as Regular.